ArticleClinical and translational science2025

Real-World Evaluation of Outcomes and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Pediatric Patients With Cystic Fibrosis: A Retrospective Study.

Nicola Perrotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.